Aakash Desai

7.3k total citations · 1 hit paper
139 papers, 1.9k citations indexed

About

Aakash Desai is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Aakash Desai has authored 139 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 24 papers in Economics and Econometrics. Recurrent topics in Aakash Desai's work include Lung Cancer Treatments and Mutations (24 papers), Economic and Financial Impacts of Cancer (20 papers) and COVID-19 and healthcare impacts (15 papers). Aakash Desai is often cited by papers focused on Lung Cancer Treatments and Mutations (24 papers), Economic and Financial Impacts of Cancer (20 papers) and COVID-19 and healthcare impacts (15 papers). Aakash Desai collaborates with scholars based in United States, Canada and China. Aakash Desai's co-authors include Bishal Gyawali, Gary H. Lyman, Nicole M. Kuderer, Jinping Lai, Sonia Sandhu, Dalbir S. Sandhu, Maryam B. Lustberg, Solange Peters, Cristiane Decat Bergerot and Vivek Subbiah and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Aakash Desai

124 papers receiving 1.9k citations

Hit Papers

Mitigating long-term and delayed adverse events associate... 2023 2026 2024 2025 2023 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aakash Desai United States 23 797 380 355 253 249 139 1.9k
Christopher J. Johnson United States 25 1.3k 1.6× 425 1.1× 350 1.0× 265 1.0× 618 2.5× 41 2.7k
Saadettin Kılıçkap Türkiye 23 1.2k 1.5× 540 1.4× 228 0.6× 67 0.3× 236 0.9× 201 2.2k
Humaid O. Al‐Shamsi United Arab Emirates 18 1.2k 1.5× 397 1.0× 264 0.7× 132 0.5× 67 0.3× 93 1.7k
Bingfeng Han China 13 509 0.6× 382 1.0× 349 1.0× 73 0.3× 213 0.9× 34 1.6k
Xabier García‐Albéniz United States 28 1.1k 1.4× 546 1.4× 464 1.3× 217 0.9× 149 0.6× 88 2.5k
Eva Segelov Australia 25 1.4k 1.8× 419 1.1× 375 1.1× 91 0.4× 526 2.1× 158 2.4k
Henrike E. Karim‐Kos Netherlands 27 1.4k 1.7× 582 1.5× 356 1.0× 119 0.5× 396 1.6× 67 2.7k
Mazen Hassanain Saudi Arabia 24 476 0.6× 233 0.6× 216 0.6× 121 0.5× 436 1.8× 98 2.1k
Hassan Errihani Morocco 25 1.3k 1.7× 568 1.5× 291 0.8× 123 0.5× 335 1.3× 306 2.6k
George Dranitsaris Canada 28 774 1.0× 247 0.7× 350 1.0× 449 1.8× 148 0.6× 105 2.3k

Countries citing papers authored by Aakash Desai

Since Specialization
Citations

This map shows the geographic impact of Aakash Desai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aakash Desai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aakash Desai more than expected).

Fields of papers citing papers by Aakash Desai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aakash Desai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aakash Desai. The network helps show where Aakash Desai may publish in the future.

Co-authorship network of co-authors of Aakash Desai

This figure shows the co-authorship network connecting the top 25 collaborators of Aakash Desai. A scholar is included among the top collaborators of Aakash Desai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aakash Desai. Aakash Desai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Soefje, Scott A., et al.. (2025). Subcutaneous Immunotherapies in Solid Tumors: Are We Truly Expanding Access and Efficiency?. JCO Oncology Practice. 22(2). 181–184.
3.
Yuan, Qinghua, Emily Castellanos, Aaron B. Cohen, et al.. (2024). P4.07F.01 Real World Characteristics and Distant Metastasis Free Survival of Patients with Early NSCLC Treated with Chemoimmunotherapy. Journal of Thoracic Oncology. 19(10). S383–S383. 1 indexed citations
5.
Desai, Aakash, Daheui Choi, Þorvarður R. Hálfdánarson, et al.. (2024). Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Cancers. 16(10). 1861–1861. 1 indexed citations
7.
Desai, Aakash, et al.. (2024). ctDNA for the Evaluation and Management of EGFR-Mutant Non-Small Cell Lung Cancer. Cancers. 16(5). 940–940. 18 indexed citations
8.
Khosla, Atulya Aman, et al.. (2024). Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies. Current Oncology Reports. 26(1). 80–89.
9.
Singhi, Eric K., et al.. (2023). OA10.03 Assessing Availability and Demand for Patient-Friendly Resources in Lung Cancer Care: The Patient Perspective. Journal of Thoracic Oncology. 18(11). S65–S66. 1 indexed citations
10.
Lustberg, Maryam B., Nicole M. Kuderer, Aakash Desai, Cristiane Decat Bergerot, & Gary H. Lyman. (2023). Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship. Nature Reviews Clinical Oncology. 20(8). 527–542. 123 indexed citations breakdown →
11.
Desai, Aakash, Hani M. Babiker, Mohamad Bassam Sonbol, et al.. (2023). Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience. JCO Precision Oncology. 7(7). e2200706–e2200706. 30 indexed citations
12.
Reuss, Joshua E., Nishant Gandhi, Phillip Walker, et al.. (2023). Spectrum of acquired KRAS mutations in driver mutation-positive non-small cell lung cancer.. Journal of Clinical Oncology. 41(16_suppl). 9069–9069.
13.
Desai, Aakash, Michael Glover, Gavin Hui, et al.. (2022). Racial Diversity and Reporting in United States Food and Drug Administration Registration Trials for Thoracic Malignancies from 2006 to 2020. Cancer Investigation. 41(1). 43–47. 1 indexed citations
14.
Adashek, Jacob J., et al.. (2022). Tissue-Agnostic Activity of BRAF plus MEK Inhibitor in BRAF V600–Mutant Tumors. Molecular Cancer Therapeutics. 21(6). 871–878. 29 indexed citations
15.
Banerjee, Rahul, Aakash Desai, Muhammad Aziz, et al.. (2022). Financial toxicity in hematological malignancies: a systematic review. Blood Cancer Journal. 12(4). 74–74. 33 indexed citations
16.
Adashek, Jacob J., Aakash Desai, Alexander Andreev-Drakhlin, et al.. (2021). Hallmarks of RET and Co-occuring Genomic Alterations inRET-aberrant Cancers. Molecular Cancer Therapeutics. 20(10). 1769–1776. 33 indexed citations
17.
Desai, Aakash, et al.. (2020). Financial conflicts of interest among National Comprehensive Cancer Network clinical practice guideline panelists in 2019. Cancer. 126(16). 3742–3749. 12 indexed citations
18.
Desai, Aakash, et al.. (2020). Category of evidence and consensus underlying National Comprehensive Cancer Network guidelines: Is there evidence of progress?. International Journal of Cancer. 148(2). 429–436. 12 indexed citations
19.
Desai, Aakash, Rohit Gupta, Shailesh Advani, et al.. (2020). Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta‐analysis of cohort studies. Cancer. 127(9). 1459–1468. 89 indexed citations
20.
Desai, Aakash, et al.. (2018). Calvarial osteomyelitis and intracranial extension post-Mohs micrographic surgery. BMJ Case Reports. 2018. bcr–2018.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026